Just like racing, in my cancer world, I need to get the research car in the best position possible before I turn it over to the closing driver – maybe that’s NIH, a drug company, or someone else. But we have to build momentum if we want a chance to win. That’s why I’m working and investing in the early stages  of the research race.

Only focusing on one or two legs doesn’t get us where we need to be as fast as needed. This is kind of how cancer treatment development and research works. Think of it like a cancer relay race.

Be cautious if reading or listening to news from international outlets, understand the rules they are playing by.

If you’re doing business in another county, you need to understand the rules and comply.

Foundation does things differently, and after 10+ years of making contributions, I know our process works. Let me share how you can maximize your contribution dollars.

In this episode, Macklin and Giovanis discuss the power of math and collaboration in cancer research.

A promising study shows that certain may more safely help detect and treat cancer. Researchers tested several types of tiny iron oxide particles—similar to those already approved by the FDA for other uses—to see how they affect the body and where they travel after injection.

2025 Symposium: Improving Breast Cancer Outcomes // Revealing and Targeting Immune Interaction

JKTG-funded project aims to answer question: Why do cancer cells selectively colonize in the liver?

In the new episode of Driving Research, Ted talks with Dr. Laura Heiser (OHSU) about treating the toughest cancers—and how teaming up with JKTG brought unexpected lessons, in and out of the lab.

How many legs does a dog have if you call a tail a leg? Still four. Saying it doesn't make it true. To get to the “truth” we need to filter out things that could alter our perception.

New project reflects JKTG focus on building collaborative research to fast-track cancer breakthroughs

The variation in cost of living across the country factors into recent discussions of the One Big Beautiful Bill but rarely gets any focus. Uniform application of deductions or limitations raises  questions of fairness and equity related to where live across the country.

With all the recent negotiations in Congress related to the new One Big Beautiful Bill, I thought I would offer an outline of the various...

The point: you need to get into the details and find out how things are put together; how exactly they work. to move forward effectively and efficiently...in racing and in cancer research.

If we would look at things under the umbrella of finiteness, tough choices would be much clearer– and our goals would be achievable.

 Today ,we face a massive national debt – $36 trillion – regularly spending more as a country than we take in. This is unsustainable and more importantly unbearable for future taxpayers. But to better understand our nation’s finances and debt, there are four important questions we need to answer.

The trick is to spread all your peanut butter evenly without tearing the bread. It’s the same when you budget. Think about this in the context of the Federal budget. The peanut butter is funding or resources, and the bread are the programs funded. Too little funding in one spot, and something suffers. The federal budget and related Congressional debates can feel far removed for most of us, but putting it in a different context hopefully helps people engage.

New podcast, Driving Research hosted by Ted Giovanis, features conversations with the scientists/clinicians partnering with the JKTG Foundation to change the way we discover, diagnose, and treat cancer.

This year’s event, titled Improving Breast Cancer Outcomes: Revealing and Targeting Tumor-Immune Interactions, will take place October 15, 2025, in Washington, D.C.